Glycemic Trends in Patients With Thyroid Eye Disease Treated With Teprotumumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Glycemic Trends in Patients with Thyroid Eye Disease Treated with Teprotumumab in 3 Clinical Trials
Ophthalmology 2024 Jul 01;131(7)815-826, TJ Smith, D Cavida, K Hsu, S Kim, Q Fu, G Barbesino, ST Wester, RJ Holt, RK BhattacharyaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.